PAVmed (PAVM) Capital Expenditures Growth (3y) (2019 - 2025)
PAVmed (PAVM) Capital Expenditures Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | 2.15% |
| 10 | PAVmed | 11.18 Mn | 9.64 Mn | -4,000.00 | -63.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -63.92% |
| Sep 30, 2025 | -78.83% |
| Jun 30, 2025 | -71.67% |
| Mar 31, 2025 | -78.14% |
| Dec 31, 2024 | -85.37% |
| Jun 30, 2024 | -70.84% |
| Mar 31, 2024 | 5.27% |
| Dec 31, 2023 | 183.87% |
| Sep 30, 2023 | 81.71% |
| Jun 30, 2023 | -29.05% |
| Mar 31, 2023 | 135.13% |
| Dec 31, 2022 | 430.15% |
| Jun 30, 2022 | 151.98% |
| Mar 31, 2022 | 476.23% |
| Dec 31, 2021 | 640.50% |
| Mar 31, 2020 | -27.74% |
| Jun 30, 2019 | 125.64% |
| Mar 31, 2019 | -37.90% |